Jagsonpal Pharmaceuticals Ltd Share Price
(JAGSNPHARM)
₹209.5▲0.63%
as on 01:07PM, 12 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -13.84 % |
3 Month Return | -21.49 % |
1 Year Return | + 80.24 % |
Market Stats | |
Previous Close | ₹208.18 |
Open | ₹210.90 |
Volume | 77.82K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,382.05Cr |
P/E Ratio
0PEG Ratio
0Market Cap
₹1,382.05 Cr
P/B Ratio
3.95
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
12.97
Key events for Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Faces USFDA Warning - 23 Feb, 2025
Jagsonpal Pharmaceuticals Allocates Equity Shares Under ESOP - 17 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, JAGSNPHARM stock has moved up by 28.9%
Retail Holding Up
Retail Investor have increased holdings from 29.62% to 30.08% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 0.11% to 0.00% in Dec 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 2.30% to 2.10% in Dec 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 67.97% to 67.81% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 67.81% | ||
Foreign Institutions | 2.1% | ||
Mutual Funds | 0% | ||
Retail Investors | 30.08% | 1.57 | |
Others | 0% |
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 707.83% since last year same period to ₹31.99Cr in the Q3 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 179.14% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹5 - translating a dividend yield of 4.80%.
Read More about DividendsBearish
Neutral
Bullish
Jagsonpal Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,382.05 Cr | 472.15% | 0.52 | NA | NA | |
NA | ₹790.42 Cr | 32.8% | 0.51 | NA | NA | |
NA | ₹245.29 Cr | 261.58% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹1,034.71 Cr | 1916.89% | 0.53 | NA | NA | |
NA | ₹9.86 Cr | 11.3% | 0.69 | NA | NA |
Organisation | Jagsonpal Pharmaceuticals Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Jagsonpal Pharmaceuticals Ltd share price today stands at ₹209.5, Open: ₹210.9, Previous Close: ₹208.18, High: ₹210.95, Low: ₹206.48, 52 Week High: ₹328.04, 52 Week Low: ₹109.44.
Jagsonpal Pharmaceuticals Ltd is listed on NSE
Jagsonpal Pharmaceuticals Ltd is listed on BSE
Today's traded volume of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is 77.82K.
Today's market capitalisation of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is ₹1382.05Cr.
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) share price is ₹209.5. It is down -36.14% from its 52 Week High price of ₹328.04
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) share price is ₹209.5. It is up 91.43% from its 52 Week Low price of ₹109.44